Skip to content

Endoscopic sphincterotomy versus endoscopic papillary balloon dilation in the treatment for choledocholithiasis: a prospective randomized controlled study

Endoscopic sphincterotomy versus endoscopic papillary balloon ditation in the treatment for choledocholithiasis: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002341
Enrollment
Unknown
Registered
2012-07-14
Start date
2012-07-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledocholithiasis

Interventions

endoscopic sphincterotomy:endoscopic sphincterotomy
endoscopic papillary balloon dilation:endoscopic papillary balloon dilation
endoscopic sphincterotomy combined with endoscopic:endoscopic sphincterotomy combined with endoscopic papillary balloon dilation

Sponsors

Department of Gastroenterology, Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age over 18 years; at least 10mm diameter of the common bile duct stone on radiographic image

Exclusion criteria

Exclusion criteria: A history of Billroth II or Roux-en-Y, endoscopic sphincterotomy or endoscopic papillary balloon dilation; severe cardiovascular or neurologic disorder, haemostatic disorders; concomitant pancreatic or biliary malignant disorders, intrahepatic stone disease

Design outcomes

Primary

MeasureTime frame
Success rate for stone removal;Post-procedure complication;

Secondary

MeasureTime frame
Days of hospitalization;Cost of hospitalization;Time of procedure;Frequency of use of mechanical lithotripsy;Cost of procedur;

Countries

China

Contacts

Public ContactFachao Zhi
zfc@fimmu.com+86 020 61641532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026